Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study von Meric-Bernstam, Funda, Hurwitz, Herbert, Raghav, Kanwal Pratap Singh, McWilliams, Robert R, Fakih, Marwan, VanderWalde, Ari, Swanton, Charles, Kurzrock, Razelle, Burris, Howard, Sweeney, Christopher, Bose, Ron, Spigel, David R, Beattie, Mary S, Blotner, Steven, Stone, Alyssa, Schulze, Katja, Cuchelkar, Vaikunth, Hainsworth, John

Volltext

Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer von Truty, Mark J., Kendrick, Michael L., Nagorney, David M., Smoot, Rory L., Cleary, Sean P., Graham, Rondell P., Goenka, Ajit H., Hallemeier, Christopher L., Haddock, Michel G., Harmsen, William S., Mahipal, Amit, McWilliams, Robert R., Halfdanarson, Thorvardur R., Grothey, Axel F.

Volltext

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer von Hu, Chunling, Hart, Steven N, Polley, Eric C, Gnanaolivu, Rohan, Shimelis, Hermela, Lee, Kun Y, Lilyquist, Jenna, Na, Jie, Moore, Raymond, Antwi, Samuel O, Bamlet, William R, Chaffee, Kari G, DiCarlo, John, Wu, Zhong, Samara, Raed, Kasi, Pashtoon M, McWilliams, Robert R, Petersen, Gloria M, Couch, Fergus J

Volltext

Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma von Graham, Rondell P., MBBS, Barr Fritcher, Emily G, Pestova, Ekaterina, PhD, Schulz, John, Sitailo, Leonid A., PhD, Vasmatzis, George, PhD, Murphy, Stephen J., PhD, McWilliams, Robert R., MD, Hart, Steven N., PhD, Halling, Kevin C., MD, PhD, Roberts, Lewis R., MB, ChB, PhD, Gores, Gregory J., MD, Couch, Fergus J., PhD, Zhang, Lizhi, MD, Borad, Mitesh J., MD, Kipp, Benjamin R., PhD

Volltext

Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy von KOPETZ, Scott, CHANG, George J, OVERMAN, Michael J, ENG, Cathy, SARGENT, Daniel J, LARSON, David W, GROTHEY, Axel, VAUTHEY, Jean-Nicolas, NAGORNEY, David M, MCWILLIAMS, Robert R

Volltext

Anorectal melanoma von Fastner, Suzanne, Hieken, Tina J., McWilliams, Robert R., Hyngstrom, John

Volltext

The role of microbiome in pancreatic cancer von Li, Jenny Jing, Zhu, Mojun, Kashyap, Purna C., Chia, Nicholas, Tran, Nguyen H., McWilliams, Robert R., Bekaii-Saab, Tanios S., Ma, Wen Wee

Volltext

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147 von GONSALVES, Wilson I, MAHONEY, Michelle R, HUBBARD, Joleen M, CHAN, Emily, NAIR, Suresh, BERENBERG, Jeffrey L, MCWILLIAMS, Robert R, SARGENT, Daniel J, NELSON, Garth D, ALBERTS, Steven R, SINICROPE, Frank A, GOLDBERG, Richard M, LIMBURG, Paul J, THIBODEAU, Stephen N, GROTHEY, Axel

Volltext

A single-institution experience with 491 cases of small bowel adenocarcinoma von Halfdanarson, Thorvardur R., M.D, McWilliams, Robert R., M.D, Donohue, John H., M.D, Quevedo, J. Fernando, M.D

Volltext

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations von DeLeon, Thomas T., Almquist, Daniel R., Kipp, Benjamin R., Langlais, Blake T., Mangold, Aaron, Winters, Jennifer L., Kosiorek, Heidi E., Joseph, Richard W., Dronca, Roxana S., Block, Matthew S., McWilliams, Robert R., Kottschade, Lisa A., Rumilla, Kandelaria M., Voss, Jesse S., Seetharam, Mahesh, Sekulic, Aleksandar, Markovic, Svetomir N., Bryce, Alan H.

Volltext

The use of pembrolizumab for the treatment of metastatic uveal melanoma von Kottschade, Lisa A, McWilliams, Robert R, Markovic, Svetomir N, Block, Matthew S, Villasboas Bisneto, Jose, Pham, Anthony Q, Esplin, Brandt L, Dronca, Roxana S

Volltext

Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005) von CORSINI, Michele M, MILLER, Robert C, LOTT, Matthew J, GUNDERSON, Leonard L, HADDOCK, Michael G, DONOHUE, John H, FARNELL, Michael B, NAGORNEY, David M, JATOI, Aminah, MCWILLIAMS, Robert R, KIM, George P, BHATIA, Sumita

Volltext

Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial von Hieken, Tina J., Nelson, Garth D., Flotte, Thomas J., Grewal, Eric P., Chen, Jun, McWilliams, Robert R., Kottschade, Lisa A., Yang, Lu, Domingo-Musibay, Evidio, Dronca, Roxana S., Yan, Yiyi, Markovic, Svetomir N., Dimou, Anastasios, Montane, Heather N., Erskine, Courtney L., Piltin, Mara A., Price, Daniel L., Khariwala, Samir S., Hui, Jane, Strand, Carrie A., Harrington, Susan M., Suman, Vera J., Dong, Haidong, Block, Matthew S.

Volltext

Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma von Zakharia, Yousef, McWilliams, Robert R, Rixe, Olivier, Drabick, Joseph, Shaheen, Montaser F, Grossmann, Kenneth F, Kolhe, Ravindra, Pacholczyk, Rafal, Sadek, Ramses, Tennant, Lucinda L, Smith, Christopher M, Kennedy, Eugene P, Link Jr, Charles J, Vahanian, Nicholas N, Yu, Jiayi, Shen, Steven S, Brincks, Erik L, Rossi, Gabriela R, Munn, David, Milhem, Mohammed

Volltext

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling von MCWILLIAMS, Robert R, WIEBEN, Eric D, RABE, Kari G, PEDERSEN, Katrina S, YANHONG WU, SICOTTE, Hugues, PETERSEN, Gloria M

Volltext

Malignant melanoma in the 21st century, Part 1: Epidemiology, risk factors, screening, prevention, and diagnosis von MARKOVIC, Svetomir N, ERICKSON, Lori A, LAMAN, Susan D, KOTTSCHADE, Lisa A, MAPLES, William J, PITTELKOW, Mark R, PULIDO, Jose S, CAMERON, J. Douglas, CREAGAN, Edward T, RAO, Ravi D, WEENIG, Roger H, POCKAJ, Barbara A, BARDIA, Aditya, VACHON, Celine M, SCHILD, Steven E, MCWILLIAMS, Robert R, HAND, Jennifer L

Volltext

Undifferentiated Pancreatic Carcinomas Display Enrichment for Frequency and Extent of PD-L1 Expression by Tumor Cells von Lehrke, Heidi D, Graham, Rondell P, McWilliams, Robert R, Lam-Himlin, Dora M, Smyrk, Thomas C, Jenkins, Sarah, Dong, Haidong, Zhang, Lizhi

Volltext

Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma von McWilliams, Robert R., Petersen, Gloria M., Rabe, Kari G., Holtegaard, Leonard M., Lynch, Pamela J., Bishop, Michele D., Highsmith, W. Edward

Volltext

Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis von Markovic, Svetomir N., MD, PhD, Erickson, Lori A., MD, Rao, Ravi D., MBBS, McWilliams, Robert R., MD, Kottschade, Lisa A., RN, Creagan, Edward T., MD, Weenig, Roger H., MD, Hand, Jennifer L., MD, Pittelkow, Mark R., MD, Pockaj, Barbara A., MD, Bardia, Aditya, MD, Vachon, Celine M., PhD, Schild, Steven E., MD, Laman, Susan D., MD, Maples, William J., MD, Pulido, Jose S., MD, MS, MPH, MBA, Cameron, J. Douglas, MD

Volltext

Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study von Pedersen, Katrina S., Kim, George P., Foster, Nathan R., Wang-Gillam, Andrea, Erlichman, Charles, McWilliams, Robert R.

Volltext